巴斯夫与Acies Bio合作，推动个人和家庭护理原料的可持续生产-动脉网

BASF partners with Acies Bio to drive sustainable production of Personal and Home Care ingredients

D-Pharm 等信源发布 2024-11-07 11:24



可切换为仅中文







BASF and Acies Bio, one of Europe’s leading biotechnology companies, have entered into a transformative partnership to further develop a platform for fermentation technology from Methanol for the production of fatty alcohols. Fatty alcohols are essential building blocks for several ingredients in the home and personal care markets, in particular surfactants.

巴斯夫和欧洲领先的生物技术公司之一Acies Bio已经建立了变革性伙伴关系，以进一步开发甲醇发酵技术平台，生产脂肪醇。脂肪醇是家庭和个人护理市场中几种成分的重要组成部分，特别是表面活性剂。

Acies Bio’s biotechnological expertise complements BASF’s drive for innovative solutions and contributes to shaping a more sustainable future. .

Acies Bio的生物技术专业知识补充了巴斯夫对创新解决方案的推动，并有助于塑造更可持续的未来。

Acies Bio has developed the “OneCarbonBio”, a fully flexible synthetic biology platform designed to efficiently convert renewable methanol, derived from captured CO2 emissions, into a variety of chemical raw materials. Under the terms of the partnership, BASF’s Care Chemicals division and Acies Bio will use the specialized microbes and scale up the fermentation process to produce fatty acids and derivatives serving to manufacture various chemical compounds.

Acies Bio开发了“OneCarbonBio”，这是一个完全灵活的合成生物学平台，旨在有效地将捕获的二氧化碳排放产生的可再生甲醇转化为各种化学原料。根据该合作协议，巴斯夫护理化学品部门和Acies Bio将利用专门的微生物，扩大发酵过程，生产用于制造各种化合物的脂肪酸和衍生物。

BASF will contribute its expertise in developing processes, providing integrated value chain solutions and accessing global markets. .

巴斯夫将在开发流程、提供综合价值链解决方案和进入全球市场方面贡献其专业知识。

Acies Bio and BASF aim to combine their strengths in a co-development effort and to build on their combined research and development expertise. For BASF, the expected benefits of the project include increased scale and flexibility, leading to a diversification of the renewable feedstock portfolio and contributing to the resilience of Care Chemicals’ global supply chain.

Acies Bio和BASF的目标是在共同开发工作中结合各自的优势，并以其综合研究和开发专业知识为基础。对于巴斯夫来说，该项目的预期收益包括增加规模和灵活性，从而使可再生原料组合多样化，并有助于提高护理化学品全球供应链的弹性。

“Biotechnology complements our chemistry to create a more sustainable future,” said Dr. Matthias Maase, Global Director Sustainability, Care Chemicals BASF. “We are very pleased to have found the right partner in Acies Bio to further develop this innovation at an early stage. With a collaborative and interdisciplinary approach, our research scope of the partnership covers the entire chain from production strain development to large scale manufacturing.

巴斯夫Care Chemicals可持续发展全球总监马蒂亚斯·马斯博士说：“生物技术补充了我们的化学，创造了一个更可持续的未来。”。“我们很高兴在Acies Bio找到合适的合作伙伴，在早期阶段进一步开发这项创新。通过合作和跨学科的方法，我们的合作研究范围涵盖了从生产菌株开发到大规模制造的整个链条。

This will be of benefit to our customers in Personal Care, Home Care and I&I and Industrial Formulators worldwide.” .

这将有利于我们在全球范围内的个人护理、家庭护理、I＆I和工业配方设计师的客户。”。

Dr. Gregor Kosec, Director of R&D at Acies Bio, said, “Partnering with BASF marks an important milestone, reflecting a significant recognition of Acies Bio’s R&D efforts. By combining our advanced microbial production strains and the OneCarbonBio platform with BASF’s proven process development and supply chain expertise, we are poised to bring our technologies to a global scale.

Acies Bio研发总监Gregor Kosec博士表示：“与巴斯夫的合作标志着一个重要的里程碑，反映了对Acies Bio研发工作的重大认可。通过将我们先进的微生物生产菌株和OneCarbonBio平台与巴斯夫成熟的工艺开发和供应链专业知识相结合，我们准备将我们的技术推向全球规模。

This collaboration demonstrates the transformative potential of Acies Bio’s microbial innovations to drive net-zero production of specialty and industrial chemicals.” .

这种合作证明了Acies Bio微生物创新的变革潜力，以推动专业和工业化学品的净零生产。”。

https://www.bionity.com/en/news/1184835/basf-partners-with-acies-bio-to-drive-sustainable-production-of-personal-and-home-care-ingredients.html

Breakthrough for an Alternative to Crude Oil & Palm Oil

原油和棕榈油替代品的突破

OLIPI Receives €1.8 Million Seed Funding for Further Development of CO2-Neutral Climate Oil

Read news

阅读新闻